TLSA Tiziana Life Sciences Ltd
Company Analysis
Latest News
π’ Tiziana Life Sciences is trading 7.6% up in after-hours trading after completing Alzheimerβs trial enrollment
Tiziana Life Sciences is trading at $1.13, up 7.62%, in after-hours trading; a clinical-trial milestone may have supported the gain. - The company announced...
Tiziana Completes Alzheimer's Trial Enrollment, but Can a $140 Million Biotech Survive the Long Road to Proof?
Shares of Tiziana Life Sciences ticked up 3.8% in pre-market trading to $1.09 after the company announced it dosed the final patient in its Phase 2 trial of an...
π’ Tiziana Life Sciences is trading 3.8% up in pre-market after last patient began dosing, completing enrollment
Tiziana Life Sciences is trading 3.8% up in pre-market at $1.09, after the last patient began dosing in its Phase 2 trial of intranasal foralumab for...
π’ Tiziana Life Sciences is trading 2.9% up in pre-market with no clear company catalyst identified
Tiziana Life Sciences is trading at $1.08, up 2.9%, with no clearly linked company catalyst identified for October 16. - Shares compare with the October 15...
π΄ Tiziana Life Sciences is trading 5.5% down today as inflation and rate concerns weighed on markets
Tiziana Life Sciences is trading at $1.03 (-5.50%) amid broader market pressure; no company-specific announcement explaining the decline was identified. -...
π΄ Tiziana Life Sciences is trading 10% down on October 12, 2026 β without clear company-specific catalyst
Tiziana Life Sciences is trading at $1.07, down 10.08%, with no clear company-specific catalyst identified for the October 12 decline. - The latest company...
π΄ Tiziana Life Sciences is trading 6.3% down on October 12, 2026 with no clear catalyst identified
Tiziana Life Sciences is trading 6.3% down at $1.11, with no clear catalyst identified for the October 12, 2026 decline. - No specific company announcement...
π’ Tiziana Life Sciences is trading 10.18% up with no confirmed company-specific announcement
Tiziana Life Sciences is trading 10.18% up at $1.25 on October 9, 2026, with no confirmed company-specific announcement identified for the move. - The...
π’ Tiziana Life Sciences is trading 8% up with no confirmed company-specific catalyst
Tiziana Life Sciences is trading at $1.22, up 7.96%, with no confirmed company-specific catalyst for the move. - Its latest listed announcement was a September...
π’ Tiziana Life Sciences is trading 5% up with no confirmed catalyst
Tiziana Life Sciences is trading 5.14% higher at $1.12 on October 6, 2026; no confirmed catalyst for the intraday rise was found. - Its latest releases were...
π’ Tiziana Life Sciences is trading 9.72% up in pre-market
Tiziana Life Sciences is trading 9.72% up in pre-market at $1.23; available evidence does not establish a specific catalyst for the move. - The shares closed...
π’ Tiziana Life Sciences is trading 6% up today; earlier FDA filing remains clearest catalyst
Tiziana Life Sciences is trading at $1.18, up 5.86%, with its September 30 FDA request the clearest company-specific catalyst; the precise cause of the October...
Tiziana Asks FDA for Special Drug Status in a Rare Brain Disease β But Can a Filing Alone Justify the Rally?
Shares of Tiziana Life Sciences jumped 8% to $1.03 on September 30 after the micro-cap biotech disclosed it had asked the FDA for orphan drug designation β a...
π’ Tiziana Life Sciences is trading 12.2% up today after seeking FDA orphan designation for foralumab
Tiziana Life Sciences is trading 12.19% up at $1.07 after requesting FDA orphan drug designation for intranasal foralumab to treat multiple system atrophy. -...
π’ Tiziana Life Sciences is trading 8% up today after requesting FDA orphan drug designation
Tiziana Life Sciences is trading 8% higher at $1.03 after requesting FDA orphan drug designation for intranasal foralumab to treat multiple system atrophy. -...
π’ Tiziana Life Sciences is trading 9.05% up in pre-market with no clear company-specific catalyst identified
Tiziana Life Sciences is trading at $1.04, up 9.05%, in pre-market on September 30, 2026, with no clear company-specific catalyst identified. - September 29...
π’ Tiziana Life Sciences is trading 15.3% up in after-hours trading
Tiziana Life Sciences is trading at $1.10, up 15.34%, with no clear after-hours catalyst identified. - No new company announcement dated September 29 was...
π’ Tiziana Life Sciences is trading 5% up in pre-market
Tiziana Life Sciences is trading at $1.03, up 5.05% in pre-market, alongside recent trial news; available reporting does not establish that the news drove the...
π’ Tiziana Life Sciences is trading 5% up in after-hours trading
Tiziana Life Sciences is trading at $1.03, up 5.05% in after-hours trading; available reporting does not establish a cause for the move. - On September 28,...
π’ Tiziana Life Sciences is trading 8.8% up in pre-market with no clear catalyst identified
Tiziana Life Sciences is trading at $1.10, up 8.84% in pre-market, with no clear company-specific catalyst identified. - No company-specific announcement...